Published in Am J Respir Crit Care Med on September 01, 2000
Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast | NCT00947453
Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol (2002) 2.83
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest (2002) 2.52
Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol (2008) 1.71
Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J (2004) 1.64
Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol (2005) 1.56
A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax (2005) 1.55
Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.48
Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol (2002) 1.45
ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6. Proc Natl Acad Sci U S A (2012) 1.42
Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS One (2009) 1.14
Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol (2007) 1.13
MMP9 modulates tight junction integrity and cell viability in human airway epithelia. Am J Physiol Lung Cell Mol Physiol (2009) 1.11
Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma. Thorax (2005) 1.10
A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice. J Immunol (2009) 1.04
ORMDL3 transgenic mice have increased airway remodeling and airway responsiveness characteristic of asthma. J Immunol (2014) 1.04
Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation. Environ Health Perspect (2007) 0.98
IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells. Br J Pharmacol (2010) 0.93
Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Front Immunol (2013) 0.92
The role of matrix metalloproteinases in cystic fibrosis lung disease. Eur Respir J (2011) 0.91
Potent synergistic effect of IL-3 and TNF on matrix metalloproteinase 9 generation by human eosinophils. Cytokine (2012) 0.90
Transcriptional regulation of cytokine function in airway smooth muscle cells. Pulm Pharmacol Ther (2009) 0.90
Asthmatic airway neutrophilia after allergen challenge is associated with the glutathione S-transferase M1 genotype. Am J Respir Crit Care Med (2012) 0.89
Regulation of the high affinity IgE receptor (Fc epsilonRI) in human neutrophils: role of seasonal allergen exposure and Th-2 cytokines. PLoS One (2008) 0.87
MMP induced by Gr-1+ cells are crucial for recruitment of Th cells into the airways. Eur J Immunol (2009) 0.84
Imaging Inflammation in Asthma: Real Time, Differential Tracking of Human Neutrophil and Eosinophil Migration in Allergen Challenged, Atopic Asthmatics in Vivo. EBioMedicine (2014) 0.81
Increased matrix metalloproteinase (MMP)-9 in the airway after allergen challenge. Am J Respir Crit Care Med (2001) 0.78
Increase in net activity of serine proteinases but not gelatinases after local endotoxin exposure in the peripheral airways of healthy subjects. PLoS One (2013) 0.77
Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthma. J Allergy Clin Immunol (2016) 0.77
Diospyros blancoi attenuates asthmatic effects in a mouse model of airway inflammation. Inflammation (2012) 0.77
Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma. Am J Physiol Lung Cell Mol Physiol (2014) 0.76
Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis. Ann Allergy Asthma Immunol (2011) 0.75
The differential effects of azithromycin on the airway epithelium in vitro and in vivo. Physiol Rep (2016) 0.75
Effect of tumor necrosis factor family member LIGHT (TNFSF14) on the activation of basophils and eosinophils interacting with bronchial epithelial cells. Mediators Inflamm (2014) 0.75
Alterations of serum biomarkers associated with lung ventilation function impairment in coal workers: a cross-sectional study. Environ Health (2011) 0.75
The α(1)AT and TIMP-1 Gene Polymorphism in the Development of Asthma. Comp Funct Genomics (2012) 0.75
Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma. Inflammation (2016) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Ragweed immunotherapy in adult asthma. N Engl J Med (1996) 4.69
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med (1998) 3.05
Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med (1998) 2.96
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol (2000) 2.51
Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med (2000) 2.29
Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol (2009) 2.22
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest (1994) 1.83
Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med (1997) 1.72
Association of rhinovirus infections with asthma. Clin Microbiol Rev (1999) 1.70
Predicting worsening asthma control following the common cold. Eur Respir J (2008) 1.70
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin Exp Allergy (2014) 1.65
Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol (1992) 1.63
Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62
Evolution of dry powder inhaler design, formulation, and performance. Respir Med (2002) 1.55
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Chest (1999) 1.51
Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol (1996) 1.37
Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol (1998) 1.33
The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis (1992) 1.33
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol (2001) 1.32
Peanut oil is not allergenic to peanut-sensitive individuals. J Allergy Clin Immunol (1981) 1.32
Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med (1998) 1.30
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol (1997) 1.29
Histamine inhibition of neutrophil lysosomal enzyme release: an H2 histamine receptor response. Science (1976) 1.27
In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis (1985) 1.27
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
NIH conference. Asthma. Ann Intern Med (1994) 1.22
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy (2008) 1.20
Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels. Arch Intern Med (1978) 1.18
Early life origins of asthma. J Clin Invest (1999) 1.17
Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol (2000) 1.17
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis (1991) 1.17
Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol (2000) 1.15
Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med (1996) 1.15
Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med (1995) 1.14
The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol (2000) 1.14
Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1. J Immunol (1996) 1.13
Cytokine profiles of stimulated blood lymphocytes in asthmatic and healthy adolescents across the school year. J Interferon Cytokine Res (1997) 1.12
Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. Am Rev Respir Dis (1977) 1.12
The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med (1997) 1.11
The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med (1998) 1.11
The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med (1997) 1.11
The role of viral infections in the natural history of asthma. J Allergy Clin Immunol (2000) 1.09
Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am J Respir Crit Care Med (1995) 1.09
Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1991) 1.08
IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis (1993) 1.08
Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy (2006) 1.07
Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol (1996) 1.07
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol (2000) 1.06
Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol (1998) 1.05
Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol (1995) 1.04
Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol (1998) 1.04
Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J Clin Invest (1981) 1.03
Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis (1992) 1.03
Asthma. JAMA (1997) 1.02
Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol (1988) 1.01
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccines. Am Rev Respir Dis (1979) 1.00
Soybean oil is not allergenic to soybean-sensitive individuals. J Allergy Clin Immunol (1985) 1.00
Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads. J Immunol Methods (1996) 0.99
Effect of omalizumab on peripheral blood eosinophilia in allergic asthma. Respir Med (2009) 0.98
Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis (1993) 0.98
Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol (1999) 0.97
Decreased H2 histamine response of granulocytes of asthmatic patients. J Clin Invest (1977) 0.97
Inflammatory changes associated with circadian variation in pulmonary function in subjects with mild asthma. Clin Exp Allergy (2004) 0.96
Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med (1997) 0.96
Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma. Clin Exp Allergy (2013) 0.96
The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am Rev Respir Dis (1989) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Isoproterenol inhibition of isolated human neutrophil function. J Allergy Clin Immunol (1984) 0.95
Superoxide generation by hypodense eosinophils from patients with asthma. Am Rev Respir Dis (1990) 0.94
Asthma exacerbations. 2: aetiology. Thorax (2006) 0.94
Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytes. Clin Exp Allergy (2012) 0.94
Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. Am J Respir Crit Care Med (1999) 0.93
The effect of transendothelial migration on eosinophil function. Am J Respir Cell Mol Biol (2000) 0.93
Prevalence of sensitivity to sulfiting agents in asthmatic patients. Am J Med (1986) 0.91
Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-alpha and interleukin-1 beta. Am J Respir Cell Mol Biol (1995) 0.91
Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol (1998) 0.91
The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils. J Allergy Clin Immunol (1991) 0.90
Release of lysosomal enzyme beta-glucuronidase from isolated human eosinophils. J Allergy Clin Immunol (1988) 0.90
Interferon gene expression in sputum cells correlates with the Asthma Index Score during virus-induced exacerbations. Clin Exp Allergy (2014) 0.90
The relationship of sputum eosinophilia and sputum cell generation of IL-5. J Allergy Clin Immunol (2000) 0.90
Food allergens: structure and immunologic properties. Ann Allergy (1987) 0.90
Engagement of alpha4beta7 integrins by monoclonal antibodies or ligands enhances survival of human eosinophils in vitro. J Immunol (1999) 0.89
Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis (1986) 0.89
Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis (1991) 0.89
Twelve-hour bronchodilation in asthma with a single aerosol dose of the anticholinergic compound glycopyrrolate. J Allergy Clin Immunol (1988) 0.89
Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med (1994) 0.89
Asthma in non-inner city Head Start children. Pediatrics (1998) 0.87
Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma. Am J Med (1985) 0.87